financetom
Business
financetom
/
Business
/
US EPA approves Texas' first CO2 injection well
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US EPA approves Texas' first CO2 injection well
Apr 7, 2025 3:16 PM

WASHINGTON, April 7 (Reuters) - The U.S. Environmental

Protection Agency on Monday issued Texas' first permit to allow

drilling to inject and store carbon dioxide to oil company

Occidental.

The company's Oxy Low Carbon Ventures received a so-called

Class VI permit to drill three CO2 wells in Ector County in the

Permian Basin for its Stratos direct air capture joint venture

with asset manager BlackRock ( BLK ), to inject 8.5 million

metric tons of CO2.

"EPA is committed to approving permits as quickly as

possible and ensuring they meet requirements to protect drinking

water sources," said EPA Regional Administrator Scott Mason.

Carbon sequestration had been a key part of former President

Joe Biden's administration, which sought to reduce emissions

that cause global warming. Biden's 2022 Inflation Reduction Act

had included billions of dollars' worth of subsidies for CCS

projects.

The future of those tax credits is uncertain as Republicans

seek to slash tax credits to achieve steep spending cuts in the

budget reconciliation process. The Trump administration is

weighing a cut in federal support for two major DAC projects,

including another Occidental DAC project in Texas.

In its announcement, the Trump EPA did not mention reducing

emissions but said the technology "will provide well-paying jobs

and can be implemented in an environmentally responsible way."

Texas had received a surge of interest from companies hoping

to bury carbon dioxide in its oilfields, with 43 projects

seeking federal permits for injection.

But concerns are also growing that pumping CO2 into the

ground could exacerbate earthquakes and well blowouts happening

in the Permian Basin as Texas struggles to manage wastewater

disposal under a different federal well permitting program,

potentially undermining public support.

The Texas Railroad Commission, which oversees wastewater

injection, is also seeking authority from the EPA to oversee its

own permitting program for carbon sequestration to speed up

approvals.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
WidePoint Q4 Loss Widens, Revenue Rises
WidePoint Q4 Loss Widens, Revenue Rises
Mar 25, 2026
04:37 PM EDT, 03/25/2026 (MT Newswires) -- WidePoint ( WYY ) on late Wednesday reported a Q4 loss of $0.09 per diluted share, wider than a loss of $0.04 a year ago. Three analysts polled by FactSet expected loss of $0.01. Revenue for the quarter ended Dec. 31 increased to $42.3 million from $37.7 million a year ago. Three analysts...
United Therapeutics Insider Sold Shares Worth $5,028,919, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $5,028,919, According to a Recent SEC Filing
Mar 25, 2026
04:37 PM EDT, 03/25/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on March 24, 2026, sold 9,500 shares in United Therapeutics ( UTHR ) for $5,028,919. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,872 common shares of the company, with 40,513 shares held directly and 639,359 controlled indirectly. SEC...
ProKidney Names Greg Madison as Chief Commercial Officer
ProKidney Names Greg Madison as Chief Commercial Officer
Mar 25, 2026
04:40 PM EDT, 03/25/2026 (MT Newswires) -- ProKidney ( PROK ) said Wednesday it named Greg Madison as chief commercial officer. Madison most recently served as CEO of Shield Therapeutics. ...
Journey Medical 2025 Net Loss Narrows; Revenue Rises
Journey Medical 2025 Net Loss Narrows; Revenue Rises
Mar 25, 2026
04:38 PM EDT, 03/25/2026 (MT Newswires) -- Journey Medical ( DERM ) reported full-year 2025 net loss Wednesday of $0.47 per diluted share, narrowing from a loss of $0.72 a year earlier. A single analyst surveyed by FactSet expected a loss of $0.47 per share. Revenue for the year ended Dec. 31 was $61.9 million, up from $56.1 million a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved